Journal of Bacteriology, May 2001, p. 3032-3040, Vol. 183, No. 10
0021-9193/01/$04.00+0 DOI: 10.1128/JB.183.10.3032-3040.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Instituto de Biología Molecular y Celular de Rosario (IBR) and Departamento de Microbiologia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000-Rosario, Argentina1; Department of Biochemistry, St. Jude Children's Research Hospital, Memphis, Tennessee 381052; and Department of Biochemistry, University of Tennessee Health Science Center, Memphis, Tennessee 381633
Received 23 October 2000/Accepted 22 February 2001
Cerulenin is a fungal mycotoxin that potently inhibits fatty acid
synthesis by covalent modification of the active site thiol of the
chain-elongation subtypes of
-ketoacyl-acyl carrier protein (ACP)
synthases. The Bacillus subtilis fabF (yjaY)
gene (fabFb) encodes an enzyme that catalyzes
the condensation of malonyl-ACP with acyl-ACP to extend the growing
acyl chain by two carbons. There were two mechanisms by which B. subtilis adapted to exposure to this antibiotic. First, reporter
gene analysis demonstrated that transcription of the operon containing
the fabF gene increased eightfold in response to a
cerulenin challenge. This response was selective for the inhibition of
fatty acid synthesis, since triclosan, an inhibitor of enoyl-ACP
reductase, triggered an increase in fabF reporter gene
expression while nalidixic acid did not. Second, spontaneous mutants
arose that exhibited a 10-fold increase in the MIC of cerulenin. The
mutation mapped at the B. subtilis fabF locus, and sequence
analysis of the mutant fabF allele showed that a single
base change resulted in the synthesis of FabFb[I108F]. The purified FabFb and FabFb[I108F] proteins
had similar specific activities with myristoyl-ACP as the substrate.
FabFb exhibited a 50% inhibitory concentration
(IC50) of cerulenin of 0.1 µM, whereas the
IC50 for FabFb[I108] was 50-fold higher (5 µM). These biochemical data explain the absence of an overt growth
defect coupled with the cerulenin resistance phenotype of the mutant strain.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |